PDS Biotechnology Corporation (PDSB) Deep Dive Video
Summary
PDS Biotechnology offers high-risk, asymmetric upside if PDS0301 converts compelling Phase 2 survival data into Phase 3 success, but liquidity, dilution, and single-asset dependence remain material.
View PDSB stock page · Read the PDSB research report
Loading the video player…